Data and AI Company and a Pioneer of the Cutting-Edge Database Architecture
NEW YORK, May 12, 2022 /PRNewswire/ — AIkido Pharma Inc. AIKI (“AIkido” or the “Company”) today announced that the Company, through a fund that owns the stock, has acquired an economic interest in privately held Databricks Inc. (https://databricks.com/company/about-us). The acquisition has been funded and closed, and the asset is on the Company’s balance sheet.
In an April 25, 2022, article, Kiplinger listed Databricks as one of the “13 Hot Upcoming IPOs to Watch For in 2022,” reporting that “in August 2021, … the firm raised $1.6 billion at a $38 billion valuation in a funding round led by Morgan Stanley fund Counterpoint Global.” (https://www.kiplinger.com/investing/stocks/ipos/604149/hot-upcoming-ipos-to-watch-for-2022). Similarly, in March 2022, Forbes listed Databricks as one of the “10 Upcoming IPOs to Watch,” estimating an IPO in mid-2022 (https://www.forbes.com/advisor/investing/upcoming-ipos/). According to the article, “Databricks has become a leading purveyor of tools designed to simplify database management, implement AI and even just do great data visualization. The company claims to have more than 5,000 clients in 19 countries and says it’s on track to generate $1 billion plus in 2022 revenue, up more than 75% year over year.” Included in Databricks’s list of investors are BlackRock, CapitalG, Fidelity, Microsoft and Andreessen Horowitz (https://databricks.com/company/about-us).
Yahoo! Finance has reported that “Microsoft Corp. is both a Databricks investor and a partner, integrating a version of the startup’s software into its cloud product, Microsoft Azure.” (https://www.yahoo.com/now/microsoft-backed-databricks-plans-ipo-000123816.html). According to the company’s website, “Databricks Lakehouse runs on every major public cloud, tightly integrated with the security, compute, storage, analytics and AI services natively offered by the cloud providers,”…